A Study Comparing the Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on Plasma Levels of CoQ10 (SPARQ)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms SPARQ
- 04 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Aug 2012 New trial record